UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists : A meta-analysis of phase III multicenter randomized trials

Circulation (New York, N.Y.), 2001-01, Vol.103 (2), p.201-206

2001

Volltextzugriff (PDF)

Relation of inflammation and benefit of statins after percutaneous coronary interventions

Circulation (New York, N.Y.), 2003-04, Vol.107 (13), p.1750-1756

2003

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

Circulation (New York, N.Y.), 2001-12, Vol.104 (23), p.2767-2771

2001

Volltextzugriff (PDF)

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

The American journal of cardiology, 2004-05, Vol.93 (9), p.1092-1096

2004

Volltextzugriff (PDF)

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

Circulation (New York, N.Y.), 2001-01, Vol.103 (3), p.363-368

2001

Volltextzugriff (PDF)

Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: A pooled analysis of five randomized clinical trials

Circulation (New York, N.Y.), 2002-12, Vol.106 (24), p.3063-3067

2002

Volltextzugriff (PDF)

Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention

Circulation (New York, N.Y.), 2002-02, Vol.105 (6), p.691-696

2002

Volltextzugriff (PDF)

Meta-Analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty

Journal of the American College of Cardiology, 2004-03, Vol.43 (6), p.936-942

2004

Volltextzugriff (PDF)

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

Circulation (New York, N.Y.), 2001-08, Vol.104 (9), p.992-997

2001

Volltextzugriff (PDF)

Renal failure after percutaneous coronary intervention is associated with high mortality

Catheterization and cardiovascular interventions, 2005-04, Vol.64 (4), p.442-448

2005

Volltextzugriff (PDF)

Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention

The American journal of cardiology, 2004-03, Vol.93 (6), p.679-684

2004

Volltextzugriff (PDF)

Defining the optimal activated clotting time during percutaneous coronary intervention : Aggregate results from 6 randomized, controlled trials

Circulation (New York, N.Y.), 2001-02, Vol.103 (7), p.961-966

2001

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

European heart journal, 2002-09, Vol.23 (18), p.1441-1448

2002

Volltextzugriff (PDF)

Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention

The American journal of cardiology, 2004-08, Vol.94 (3), p.358-360

2004

Volltextzugriff (PDF)

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting

The American journal of cardiology, 2004-02, Vol.93 (3), p.356-359

2004

Volltextzugriff (PDF)

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)

The American journal of cardiology, 2005-03, Vol.95 (5), p.581-585

2005

Volltextzugriff (PDF)

Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

The American journal of cardiology, 2001-09, Vol.88 (6), p.672-674

2001

Volltextzugriff (PDF)

Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials

The American journal of cardiology, 2003-10, Vol.92 (8), p.919-923

2003

Volltextzugriff (PDF)

Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction

The American journal of cardiology, 2002-01, Vol.89 (2), p.132-136

2002

Volltextzugriff (PDF)

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk

Heart (British Cardiac Society), 2006-07, Vol.92 (7), p.945-950

2006

Volltextzugriff (PDF)

A critical appraisal of platelet glycoprotein IIb/IIIa inhibition

Journal of the American College of Cardiology, 2000-12, Vol.36 (7), p.2028-2035

2000

Volltextzugriff (PDF)

CLINICAL CHARACTERISTICS, MANAGEMENT, AND OUTCOMES OF ACUTE CORONARY SYNDROMES IN RELATION TO RIGHT BUNDLE BRANCH BLOCK ON PRESENTATION

Canadian journal of cardiology, 2015-10, Vol.31 (10), p.S97-S97

2015

Volltextzugriff (PDF)

Plasma surfactant protein-B : A novel biomarker in chronic heart failure

Circulation (New York, N.Y.), 2004-08, Vol.110 (9), p.1091-1096

2004

Volltextzugriff (PDF)

PCV6 EFFECTIVENESS OF CLOPIDOGREL IN ADDITION TO ASPIRIN COMPARED TO ASPIRIN ALONE AFTER ACUTE CORONARY SYNDROME

Value in health, 2008, Vol.11 (6), p.A382-A382

2008

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Englisch
(71)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(53)
Humans
(51)
Female
(40)
Cardiac & Cardiovascular Systems
(38)
Cardiovascular System & Cardiology
(38)
Biological And Medical Sciences
(36)
Medical Sciences
(36)
Male
(35)
Middle Aged
(31)
Aged
(29)
Treatment Outcome
(17)
Angioplasty, Balloon, Coronary
(16)
Cardiology. Vascular System
(14)
Platelet Glycoprotein Gpiib-Iiia Complex - Antagonists & Inhibitors
(14)
Stents
(14)
Pharmacology. Drug Treatments
(13)
Mortality
(12)
Cardiology
(11)
Coronary Disease - Therapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists : A meta-analysis of phase III multicenter randomized trials

Relation of inflammation and benefit of statins after percutaneous coronary interventions

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: A pooled analysis of five randomized clinical trials

Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention

Meta-Analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

Renal failure after percutaneous coronary intervention is associated with high mortality

Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention

Defining the optimal activated clotting time during percutaneous coronary intervention : Aggregate results from 6 randomized, controlled trials

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)

Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials

Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk

A critical appraisal of platelet glycoprotein IIb/IIIa inhibition

CLINICAL CHARACTERISTICS, MANAGEMENT, AND OUTCOMES OF ACUTE CORONARY SYNDROMES IN RELATION TO RIGHT BUNDLE BRANCH BLOCK ON PRESENTATION

Plasma surfactant protein-B : A novel biomarker in chronic heart failure

PCV6 EFFECTIVENESS OF CLOPIDOGREL IN ADDITION TO ASPIRIN COMPARED TO ASPIRIN ALONE AFTER ACUTE CORONARY SYNDROME

Suchergebnisse filtern